Browse by Person

Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 4.

Article

Slotman, B.J., Faivre-Finn, C., van Tinteren, H. et al. (12 more authors) (2017) Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial. Lung Cancer, 108. pp. 150-153. ISSN 0169-5002

Haslett, K., Franks, K., Hanna, G.G. et al. (12 more authors) (2016) Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study. BMJ Open, 6 (4). e010457. e010457-e010457. ISSN 2044-6055

Proceedings Paper

Haslett, K., Ashcroft, L., Bayman, N. et al. (11 more authors) (2018) PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S387-S387.

Haslett, K., Bayman, N., Franks, K. et al. (11 more authors) (2017) MA 09.11 Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) – a feasibility study. In: Journal of Thoracic Oncology. IASLC 18th World Conference on Lung Cancer, 15-18 Oct 2017, Yokohama, Japan. Elsevier , S1838-S1839.

This list was generated on Sat Jan 1 22:22:58 2022 GMT.